Charles Schwab Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Charles Schwab Trust's RMD Position: Q3 2026 in Review
Charles Schwab Trust held its ResMed (RMD) position steady in Q3 2026 at 1,590 shares worth $352K. The position accounts for 0.02% of the portfolio, ranked #147.
Charles Schwab Trust first reported a position in RMD in Q2 2025 and has held it in 6 quarters since. The position peaked at $451K in Q3 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Charles Schwab Trust held 1,590 shares of ResMed worth $352K as of Q3 2026.
- Charles Schwab Trust left its ResMed share count unchanged in Q3 2026.
- ResMed made up 0.02% of Charles Schwab Trust's portfolio in Q3 2026, its #147 holding.
- Charles Schwab Trust first reported a position in ResMed in Q2 2025 and has held it in 6 quarters since.
- Charles Schwab Trust's ResMed position peaked at $451K in Q3 2025.
- 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Charles Schwab Trust's 13F filing for Q3 2026, filed 15 Oct 2026.